RUOZI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.387
EU - Europa 14.015
AS - Asia 10.757
SA - Sud America 1.535
AF - Africa 204
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 22
Totale 54.955
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.149
GB - Regno Unito 4.926
IT - Italia 3.819
CN - Cina 3.710
SG - Singapore 3.041
HK - Hong Kong 1.647
SE - Svezia 1.365
BR - Brasile 1.274
DE - Germania 889
UA - Ucraina 625
RU - Federazione Russa 621
TR - Turchia 618
VN - Vietnam 524
FI - Finlandia 421
KR - Corea 325
FR - Francia 320
BG - Bulgaria 239
IN - India 204
ID - Indonesia 149
NL - Olanda 145
CA - Canada 116
AR - Argentina 99
IE - Irlanda 97
JP - Giappone 91
RO - Romania 80
ES - Italia 79
ZA - Sudafrica 79
BE - Belgio 78
MX - Messico 70
PL - Polonia 66
BD - Bangladesh 59
LT - Lituania 53
IQ - Iraq 51
PK - Pakistan 48
EC - Ecuador 44
IR - Iran 44
CH - Svizzera 37
AE - Emirati Arabi Uniti 35
EG - Egitto 31
CO - Colombia 30
CZ - Repubblica Ceca 27
AT - Austria 26
AU - Australia 26
MA - Marocco 26
IL - Israele 25
MY - Malesia 22
UZ - Uzbekistan 21
VE - Venezuela 19
CL - Cile 18
GR - Grecia 18
PY - Paraguay 18
PT - Portogallo 17
EU - Europa 16
UY - Uruguay 15
JO - Giordania 12
SA - Arabia Saudita 12
SN - Senegal 12
TN - Tunisia 12
TW - Taiwan 12
TH - Thailandia 11
AZ - Azerbaigian 10
DZ - Algeria 10
HU - Ungheria 10
AL - Albania 9
KE - Kenya 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
PE - Perù 9
DK - Danimarca 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
KG - Kirghizistan 7
NO - Norvegia 7
AM - Armenia 6
CR - Costa Rica 6
EE - Estonia 6
LA - Repubblica Popolare Democratica del Laos 6
LK - Sri Lanka 6
NP - Nepal 6
OM - Oman 6
PH - Filippine 6
LB - Libano 5
PA - Panama 5
PS - Palestinian Territory 5
RS - Serbia 5
BZ - Belize 4
ET - Etiopia 4
HN - Honduras 4
KH - Cambogia 4
LV - Lettonia 4
MD - Moldavia 4
TT - Trinidad e Tobago 4
YE - Yemen 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
GT - Guatemala 3
HR - Croazia 3
Totale 54.899
Salva come PNG Salva come JPEG
Città #
Southend 3.817
Santa Clara 2.734
Fairfield 2.349
Ashburn 2.281
Singapore 1.790
Chandler 1.757
Woodbridge 1.635
Hong Kong 1.631
Hefei 1.332
Jacksonville 1.265
Chicago 1.085
Houston 1.083
Seattle 997
Wilmington 991
Dearborn 954
Ann Arbor 918
Cambridge 795
Nyköping 775
Beijing 674
Los Angeles 671
London 619
Modena 537
Salt Lake City 380
Izmir 355
Seoul 274
New York 265
Princeton 249
Sofia 233
Dallas 226
Eugene 219
Council Bluffs 217
San Diego 212
The Dalles 197
Milan 196
Tampa 178
Helsinki 175
Ho Chi Minh City 170
Elk Grove Village 161
Moscow 159
Rome 155
Bologna 153
Buffalo 148
Shanghai 137
Munich 126
Des Moines 118
São Paulo 113
Jakarta 112
Redwood City 112
Hanoi 108
Lancaster 105
Bremen 94
Falls Church 88
Fremont 88
Dublin 83
Columbus 75
Frankfurt am Main 75
Reggio Emilia 73
Tokyo 73
Brussels 71
Miami 68
Sterling 68
Phoenix 67
Naples 58
Dulles 54
Florence 54
Guangzhou 52
Parma 49
Stockholm 49
Boardman 47
Orem 47
Detroit 45
Nanjing 44
Warsaw 44
Brooklyn 43
San Jose 43
Turin 43
Como 42
Chennai 39
Johannesburg 39
Atlanta 38
Kent 37
Norwalk 37
Catania 36
Kansas City 35
Denver 34
Montreal 33
Rio de Janeiro 33
Tulare 33
Napoli 32
Toronto 32
Bari 31
Boston 30
Kunming 30
Redondo Beach 30
Amsterdam 29
Jinan 28
Pittsburgh 28
Poplar 28
Belo Horizonte 27
Changsha 27
Totale 38.326
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 511
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 457
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 444
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 429
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 407
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 401
Cationic liposomes for gene transfection 393
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 392
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 389
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 385
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 383
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 382
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 377
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 370
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 369
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 363
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 361
Amphiphilic ion pairs of tobramycin with lipoamino acids 358
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 354
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 350
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 348
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 348
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 347
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 346
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 338
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 336
Vegetable cells in Papanicolaou-stained cervical smears 334
Nanomedicine: the future for advancing medicine and neuroscience 334
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 331
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 329
Polymeric nanoparticles for the drug delivery to the central nervous system 326
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 322
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 319
Brain targeting with polymeric nanoparticles: which administration route should we take? 318
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 315
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 315
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 312
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 312
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 311
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 308
Nanoparticle transport across the blood brain barrier 308
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 302
Protein corona and nanoparticles: How can we investigate on? 302
Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation 301
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 301
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 297
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 297
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 296
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 292
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 292
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 291
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 288
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 286
Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. 285
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 282
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 282
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 281
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 281
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 279
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 278
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 277
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 277
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 274
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 271
PLA/PLGA nanoparticles for sustained release of docetaxel 271
Colloidal systems for CNS drug delivery 270
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 268
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 268
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 267
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 267
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 266
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 265
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 265
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 261
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 260
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 259
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 258
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 258
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 257
Functionalization of liposomes: microscopical methods for preformulative screening 256
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 254
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 254
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 253
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 249
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 249
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 248
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 248
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 247
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 246
Ketorolac tromethamine liposomes: Encapsulation and release studies 240
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 238
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 235
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 235
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 234
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 234
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 228
Sustained Zero-Order Release of Intact Ultra-Stable Drug-Loaded Liposomes from an Implantable Nanochannel Delivery System 228
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 228
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 227
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells 227
Totale 30.362
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.350
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.347 0 0 0 0 0 362 487 701 255 899 365 278
2021/20224.234 189 486 381 289 161 212 238 229 498 332 698 521
2022/20234.919 592 536 401 482 569 711 116 437 578 91 188 218
2023/20243.460 177 202 220 286 732 356 396 426 127 89 148 301
2024/202511.116 526 176 238 820 2.136 1.467 897 755 1.082 503 1.148 1.368
2025/202611.969 1.329 851 1.566 2.785 4.348 1.090 0 0 0 0 0 0
Totale 55.364